Suchergebnisse - "Fujii, Kentaro"

PubPharm (12)

1

A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Kato, A. | Yoshifuji, A. | Komori, K. | +8

2

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

enthalten in: Clinical and experimental nephrology | 2022

von Toda, M. | Yoshifuji, A. | Kikuchi, K. | +7

ErratumIn: Clin Exp Nephrol. 2022 Mar 9;:. - PMID 35262832

3

Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19

enthalten in: Renal replacement therapy | 2022

von Toda, M. | Yoshifuji, A. | Fujii, K. | +5

4

Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19

enthalten in: Renal replacement therapy | 2022

von Toda, M. | Yoshifuji, A. | Fujii, K. | +5

5

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

enthalten in: Clinical and experimental nephrology | 2022

von Toda, M. | Yoshifuji, A. | Kikuchi, K. | +7

6

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

enthalten in: Clinical and experimental nephrology | 2022

von Toda, M. | Yoshifuji, A. | Kikuchi, K. | +7

7

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

enthalten in: Clinical and experimental nephrology | 2022

von Toda, M. | Yoshifuji, A. | Kikuchi, K. | +7

8

Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients

enthalten in: Clinical and experimental nephrology | 2022

von Toda, M. | Fujii, K. | Yoshifuji, A. | +5

9

Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19

enthalten in: Renal replacement therapy | 2022

von Toda, M. | Yoshifuji, A. | Fujii, K. | +5

10

Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients

enthalten in: Clinical and experimental nephrology | 2021

von Toda, M. | Fujii, K. | Yoshifuji, A. | +5